FORT LAUDERDALE, Fla., Feb. 21, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals (soon to be changed from Hybrid Fuels, Inc.), (Pink Sheets: HRID) announced today that the CEO met with Walgreens representatives and received approval to sell Azul Instant™ beginning in the Florida market.
"We are excited by Walgreen's decision and are confident in our ability to deliver to one of the nation's largest drug store chains. After we launch in the Florida catalog with Walgreens, we will aggressively penetrate the East Coast, followed by the West Coast and then Midwest. In addition to Walgreens, we are also targeting CVS and GNC," stated Ramiro Cadena, CEO of Nouveau Life Pharmaceuticals.
The Company recently announced the introduction of Azul Instant™, an all-natural supplement for ED that provides the millions of men suffering from the condition with a safe alternative to prescription drugs. Developed by a team of experts, the Company's goal is to create the healthiest and most effective all-natural male enhancer ever formulated. Unlike pharmaceutical drugs such as Cialis, Viagra and Levitra, Azul Instant™, carries no dangerous side effects.
About Azul Instant™
Azul Instant™ was developed by the scientific research and development team of Nouveau Life Pharmaceuticals. The Company developed the formula to provide a safe and natural alternative for erectile dysfunction. Patients will now receive the NATURAL benefits of Azul Instant™ without experiencing the side effects associated with prescription medications. While there are other natural alternative supplements on the market today, Azul Instant™ is the only male enhancement product that works within 5 minutes. Azul Instant™ lasts for up to 48 hours and has proven to help enhance sexual stamina, endurance, strength and energy with no side effects.
Azul Instant™ is marketed under Nouveau Life Pharmaceuticals, Inc. For more information, go to www.azulnow.com.
About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.; Hybrid Fuels, Inc.